U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C7H5I2NO3.C4H11NO2
Molecular Weight 510.0641
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of IODOPYRACET

SMILES

OCCNCCO.OC(=O)CN1C=C(I)C(=O)C(I)=C1

InChI

InChIKey=RERHJVNYJKZHLJ-UHFFFAOYSA-N
InChI=1S/C7H5I2NO3.C4H11NO2/c8-4-1-10(3-6(11)12)2-5(9)7(4)13;6-3-1-5-2-4-7/h1-2H,3H2,(H,11,12);5-7H,1-4H2

HIDE SMILES / InChI

Molecular Formula C7H5I2NO3
Molecular Weight 404.9284
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula C4H11NO2
Molecular Weight 105.1356
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Iodopyracet (Diodone) is a radiocontrast agent used in urography before 1950. Renal clearance of iodopyracet is characterized by supply-limited elimination at low plasma concentrations and capacity-limited elimination at high plasma levels. Iodopyracet to be an effective agent for the estimation of renal plasma flow and tubular function has been used extensively in physiological studies. In 1945 was found, that p-aminohippuric acid was in some ways superior to diodone for these estimations in man because the urine and plasma blanks are small and because diodone penetrates human red blood cells whereas p-aminohippuric acid does not.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
Doses

Doses

DosePopulationAdverse events​
10 g single, intravenous
Dose: 10 g
Route: intravenous
Route: single
Dose: 10 g
Co-administed with::
diphenhydramine(20 mg)
Sources:
unhealthy
n = 416
Health Status: unhealthy
Condition: urography
Population Size: 416
Sources:
Other AEs: Nausea and vomiting, Urticaria...
Other AEs:
Nausea and vomiting (severe, 2 patients)
Urticaria (8 patients)
Sleepiness (34 patients)
Sources:
AEs

AEs

AESignificanceDosePopulation
Sleepiness 34 patients
10 g single, intravenous
Dose: 10 g
Route: intravenous
Route: single
Dose: 10 g
Co-administed with::
diphenhydramine(20 mg)
Sources:
unhealthy
n = 416
Health Status: unhealthy
Condition: urography
Population Size: 416
Sources:
Urticaria 8 patients
10 g single, intravenous
Dose: 10 g
Route: intravenous
Route: single
Dose: 10 g
Co-administed with::
diphenhydramine(20 mg)
Sources:
unhealthy
n = 416
Health Status: unhealthy
Condition: urography
Population Size: 416
Sources:
Nausea and vomiting severe, 2 patients
10 g single, intravenous
Dose: 10 g
Route: intravenous
Route: single
Dose: 10 g
Co-administed with::
diphenhydramine(20 mg)
Sources:
unhealthy
n = 416
Health Status: unhealthy
Condition: urography
Population Size: 416
Sources:
Sourcing

Sourcing

Vendor/AggregatorIDURL
PubMed

PubMed

TitleDatePubMed
A clinical evaluation of the iodopyracet (diodrast) renogram.
1959 Jun

Sample Use Guides

3.0 g, administered i.v.
Route of Administration: Intravenous
Substance Class Chemical
Created
by admin
on Sat Dec 16 15:49:43 GMT 2023
Edited
by admin
on Sat Dec 16 15:49:43 GMT 2023
Record UNII
ZTK4026YJ5
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
IODOPYRACET
MI  
Common Name English
Diodone [WHO-DD]
Common Name English
IODOPYRACET [MI]
Common Name English
diodone [INN]
Common Name English
DIODONE
INN   MART.   WHO-DD  
INN  
Official Name English
DIODRAST
Brand Name English
CARDIOTRAST
Brand Name English
3,5-DIIODO-4-OXO-1-(4H)-PYRIDINEACETIC ACID 2,2'-IMINODIETHANOL (1:1) COMPOUND
Common Name English
DIODONE [MART.]
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C28500
Created by admin on Sat Dec 16 15:49:43 GMT 2023 , Edited by admin on Sat Dec 16 15:49:43 GMT 2023
WHO-VATC QV08AA10
Created by admin on Sat Dec 16 15:49:43 GMT 2023 , Edited by admin on Sat Dec 16 15:49:43 GMT 2023
WHO-ATC V08AA10
Created by admin on Sat Dec 16 15:49:43 GMT 2023 , Edited by admin on Sat Dec 16 15:49:43 GMT 2023
Code System Code Type Description
EPA CompTox
DTXSID1023154
Created by admin on Sat Dec 16 15:49:43 GMT 2023 , Edited by admin on Sat Dec 16 15:49:43 GMT 2023
PRIMARY
MERCK INDEX
m6353
Created by admin on Sat Dec 16 15:49:43 GMT 2023 , Edited by admin on Sat Dec 16 15:49:43 GMT 2023
PRIMARY Merck Index
INN
1763
Created by admin on Sat Dec 16 15:49:43 GMT 2023 , Edited by admin on Sat Dec 16 15:49:43 GMT 2023
PRIMARY
DRUG CENTRAL
4449
Created by admin on Sat Dec 16 15:49:43 GMT 2023 , Edited by admin on Sat Dec 16 15:49:43 GMT 2023
PRIMARY
WIKIPEDIA
DIODONE
Created by admin on Sat Dec 16 15:49:43 GMT 2023 , Edited by admin on Sat Dec 16 15:49:43 GMT 2023
PRIMARY
ChEMBL
CHEMBL2110615
Created by admin on Sat Dec 16 15:49:43 GMT 2023 , Edited by admin on Sat Dec 16 15:49:43 GMT 2023
PRIMARY
PUBCHEM
9303
Created by admin on Sat Dec 16 15:49:43 GMT 2023 , Edited by admin on Sat Dec 16 15:49:43 GMT 2023
PRIMARY
MESH
D007468
Created by admin on Sat Dec 16 15:49:43 GMT 2023 , Edited by admin on Sat Dec 16 15:49:43 GMT 2023
PRIMARY
EVMPD
SUB07197MIG
Created by admin on Sat Dec 16 15:49:43 GMT 2023 , Edited by admin on Sat Dec 16 15:49:43 GMT 2023
PRIMARY
NCI_THESAURUS
C75627
Created by admin on Sat Dec 16 15:49:43 GMT 2023 , Edited by admin on Sat Dec 16 15:49:43 GMT 2023
PRIMARY
CAS
300-37-8
Created by admin on Sat Dec 16 15:49:43 GMT 2023 , Edited by admin on Sat Dec 16 15:49:43 GMT 2023
PRIMARY
ECHA (EC/EINECS)
206-089-4
Created by admin on Sat Dec 16 15:49:43 GMT 2023 , Edited by admin on Sat Dec 16 15:49:43 GMT 2023
PRIMARY
DRUG BANK
DB13568
Created by admin on Sat Dec 16 15:49:43 GMT 2023 , Edited by admin on Sat Dec 16 15:49:43 GMT 2023
PRIMARY
FDA UNII
ZTK4026YJ5
Created by admin on Sat Dec 16 15:49:43 GMT 2023 , Edited by admin on Sat Dec 16 15:49:43 GMT 2023
PRIMARY
SMS_ID
100000082852
Created by admin on Sat Dec 16 15:49:43 GMT 2023 , Edited by admin on Sat Dec 16 15:49:43 GMT 2023
PRIMARY
Related Record Type Details
PARENT -> SALT/SOLVATE
PARENT -> SALT/SOLVATE
Related Record Type Details
ACTIVE MOIETY